EAGLE PHARMACEUTICALS INC's ticker is and the CUSIP is 269796958. A total of 3 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $138,000 | -90.0% | 3,000 | -87.0% | 0.00% | -88.9% |
| Q4 2019 | $1,382,000 | +144.2% | 23,000 | +130.0% | 0.01% | +80.0% |
| Q3 2019 | $566,000 | +1.6% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $557,000 | +5470.0% | 10,000 | +4900.0% | 0.01% | – |
| Q1 2019 | $10,000 | -98.7% | 200 | -99.0% | 0.00% | -100.0% |
| Q4 2018 | $794,000 | -70.2% | 19,700 | -48.7% | 0.01% | -66.7% |
| Q3 2018 | $2,662,000 | +255.4% | 38,400 | +287.9% | 0.02% | +250.0% |
| Q2 2018 | $749,000 | +330.5% | 9,900 | +200.0% | 0.01% | +200.0% |
| Q1 2018 | $174,000 | -86.4% | 3,300 | -86.2% | 0.00% | -77.8% |
| Q4 2017 | $1,277,000 | +275.6% | 23,900 | +319.3% | 0.01% | +200.0% |
| Q3 2017 | $340,000 | -68.5% | 5,700 | -58.4% | 0.00% | -72.7% |
| Q2 2017 | $1,081,000 | +831.9% | 13,700 | +878.6% | 0.01% | +1000.0% |
| Q1 2017 | $116,000 | -36.3% | 1,400 | -39.1% | 0.00% | -50.0% |
| Q4 2016 | $182,000 | +52.9% | 2,300 | +35.3% | 0.00% | +100.0% |
| Q3 2016 | $119,000 | -83.3% | 1,700 | -90.8% | 0.00% | -87.5% |
| Q2 2016 | $714,000 | +17750.0% | 18,400 | +18300.0% | 0.01% | – |
| Q1 2016 | $4,000 | -95.9% | 100 | -90.9% | 0.00% | -100.0% |
| Q4 2015 | $98,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 19,700 | $794,000 | 0.01% |
| SIMPLEX TRADING, LLC | 323 | $1,301,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |